´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-19±³À°ÀÏÀÚ : 2019-04-19
±³À°Àå¼Ò : º¤½ºÄÚ 201È£ ¿Ü
±³À°ÁÖÁ¦ :
2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ :
herz8@circulation.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 5Á¡ / Çʼö 1Á¡)
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ 100,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 70,000¿ø´çÀϵî·Ï: ±³¼ö ¹× °³¿øÀÇ 120,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 90,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-19 201È£ 09:30~09:45 º¸Çè ±Þ¿© ÀÌÈÄ LVAD ÇöȲ °Çý¿µ(°Ç°º¸Çè½É»çÆò°¡¿ø)
±³À°½Ã°£ 04-19 201È£ 09:45~10:00 Indication of LVAD as BTT, BTC or DT: Cardiologist¡¯s View: ¿ÀÀç¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-19 201È£ 10:00~10:15 Perioperative Management of Patients with LVAD: Surgeon¡¯s View: Á¶¾çÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-19 201È£ 10:15~10:30 Future Perspectives of LVAD in Korea ÃÖÁø¿À(¼º±Õ°üÀÇ´ë)
Åä·Ð 04-19 201È£ 10:30~11:00 Discussion ()
ÈÞ½Ä 04-19 11:00~11:10 Break ()
±³À°½Ã°£ 04-19 103È£ 11:10~11:30 How to Approach to Resistant Hypertension ÀÓ»óÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-19 103È£ 11:30~11:50 How to Manage Resistant Hypertension ½ÅÁøÈ£(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-19 103È£ 11:50~12:20 Renal Nerve Denervation: Current and Future ±èº´±Ø(¿¬¼¼ÀÇ´ë)
Åä·Ð 04-19 103È£ 12:20~12:40 Discussion ()
ÈÞ½Ä 04-19 12:40~12:45 Break ()
±³À°½Ã°£ 04-19 104È£ 12:45~13:05 Antithrombotic Therapy in Patients with NVAF Undergoing PCI : Should We Change Our Practice? °ÇöÀç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-19 104È£ 13:05~13:25 AUGUSTUS Trial : An Open-label, 2 x 2 Factorial, Randomized Trial to Evaluate the Safety of Apixaban vs.VKA and Aspirin vs. Placebo in Patients with AF and ACS and/or PCI Renato Delascio Lopes(Duke Univ. USA)
ÈÞ½Ä 04-19 13:25~13:40 Break ()
±³À°½Ã°£ 04-19 205È£ 13:40~14:00 In Memory of Hi Myung Park Shung Chull Chae(Kyungpook National Univ. Korea)
±³À°½Ã°£ 04-19 205È£ 14:00~14:20 Revascularization in Heart Failure: What We Now Know and Need to Still Learn Eric Velaquez(Yale Univ. USA)
ÈÞ½Ä 04-19 14:20~14:30 Break ()
±³À°½Ã°£ 04-19 106È£ 14:30~14:45 Fibrinolytic Therapy Versus Primary PCI in STEMI ½ÉµÎ¼±(Àü³²ÀÇ´ë)
±³À°½Ã°£ 04-19 106È£ 14:45~15:00 Can Beta-Blockers Be Terminated Post-MI? - Who Really Needs Them and How Long? À±Ã¢È¯(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-19 106È£ 15:00~15:15 PCI Strategy in Multi Vessel Disease: How and When? ¾È¼º±Õ(¿øÁÖÀÇ´ë)
±³À°½Ã°£ 04-19 106È£ 15:15~15:30 Challenges in AMI: Personalized Cardiology in the Very Elderly Population ÀÌ»ó¿±(ÃæºÏÀÇ´ë)
Åä·Ð 04-19 106È£ 15:30~16:00 Discussion ()
ÈÞ½Ä 04-19 16:00~16:10 Break ()
±³À°½Ã°£ 04-19 205È£ 16:10~16:30 ÀÇ·áºÐÀïÀÇ ÇöȲ°ú ¿øÀÎ À̵¿ÇÐ(Çѱ¹ÀÇ·áºÐÀïÁ¶Á¤ÁßÀç¿ø)
±³À°½Ã°£ 04-19 205È£ 16:30~16:50 ÀÇ·áºÐÀï(»ç°í)ÀÇ ¿Ã¹Ù¸¥ ÀÌÇØ¿Í ¿¹¹æ À±ÅÂÁß(¹ý¹«¹ýÀΠŽÅ)
±³À°½Ã°£ 04-19 205È£ 16:50~17:10 ÀÇ·áÇöÀå¿¡¼ÀÇ ÀÇ·áÀο¡ ´ëÇÑ Æø¾ð°ú ÆøÇà: ÀÇ·áÀ±¸®Àû ´ëÃ¥ ±¸¿µ¸ð(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-19 205È£ 17:10~17:30 ÀÓ»óÀ±¸®ÀÇ ÀÌÇØ ±Çº¹±Ô(ÀÌÈ¿©´ë)
Åä·Ð 04-19 205È£ 17:30~17:40 Discussion ()